PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market profile: Japan • Economy, business, and development PART 06: Healthcare system in Japan • Role of government PART 07: Key insights PART 08: Complications of infusion systems: A global perspective • Background • Incidence of HAIs • CAUTIs PART 09: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 10: Market segmentation by product • General purpose or volumetric pumps • Syringe drivers • Patient-controlled analgesia pumps • Ambulatory pumps PART 11: Market segmentation by application • Analgesia or pain management • Diabetes • Oncology • Gastroenterology • Hematology • Pediatric or neonatology PART 12: Market drivers • High prevalence of chronic diseases • Increasing use of chemotherapy • Rise in geriatric population • Favorable market conditions PART 13: Impact of drivers PART 14: Market challenges • Complications of infusion systems • Catheter-related bloodstream infections • Regulatory concerns and product recalls • Price wars PART 15: Impact of drivers and challenges PART 16: Market trends • Use of power-driven and closed infusion systems • Availability of IT-enabled devices • Focus on alternative site and homecare services PART 17: Vendor landscape • Competitive scenario • B. Braun Melsungen • Baxter • BD • Fresenius Kabi • Hospira • JMS • Nipro • Terumo • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio   Exhibit 01: Product offerings Exhibit 02: Acceptable pressure rates for infusion systems Exhibit 03: Maximum resistance during infusion therapy Exhibit 04: Japan: Facts and figures Exhibit 05: Japan: Characteristics of market Exhibit 06: Key strategies for market entry Exhibit 07: Advantages and disadvantages of business models for vendors Exhibit 08: Comparison of HAI in developed and middle and low income countries Exhibit 09: Evidence-based risk factors for CAUTIs Exhibit 10: Infusion systems market in Japan 2015-2020 ($ millions) Exhibit 11: Market metrics for infusion systems in japan Exhibit 12: Five forces analysis Exhibit 13: Segmentation of infusion systems market in Japan by product Exhibit 14: Metrics analysis of general purpose or volumetric pumps Exhibit 15: Metrics analysis of syringe drivers Exhibit 16: Metrics analysis of patient-controlled analgesia pumps Exhibit 17: Metrics analysis of ambulatory pumps Exhibit 18: Segmentation of infusion systems market in Japan by product 2015 Exhibit 19: Segmentation of infusion systems market in Japan by application Exhibit 20: Impact of drivers Exhibit 21: Impact of drivers and challenges Exhibit 22: B. Braun Melsungen: Key takeaways Exhibit 23: Baxter: Key takeaways Exhibit 24: BD: Key takeaways Exhibit 25: Fresenius Kabi: Key takeaways Exhibit 26: Hospira: Key takeaways Exhibit 27: JMS: Key takeaways Exhibit 28: Nipro: Product offerings Exhibit 29: Nipro: Key takeaways Exhibit 30: Terumo: Product offerings Exhibit 31: Terumo: Key takeaways Exhibit 32: Other prominent vendors

B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo, Animas, Medtronic, and Smiths Medical.